The global artificial organ market is set to witness robust growth at a CAGR of 7.35% during the forecast period to be worth US$6.687 billion in 2030 from US$4.691 billion in 2025.
The global artificial organs market is expanding, driven by trends like 3D printing, nanotechnology, and advanced AI. These technologies enable the creation of patient-specific organs with intricate structures and high biocompatibility. Nanomaterials are increasingly incorporated to enhance product performance and durability. AI is used in organ design and functionality is integrated with patient needs for improved treatment and higher success rates. Furthermore, the shortage of organ donors encourages patients awaiting transplants to consider artificial organs, boosting their future popularity.
The global artificial organs market is expanding, driven by trends like 3D printing, nanotechnology, and advanced AI. These technologies enable the creation of patient-specific organs with intricate structures and high biocompatibility. Nanomaterials are increasingly incorporated to enhance product performance and durability. AI is used in organ design and functionality is integrated with patient needs for improved treatment and higher success rates. Furthermore, the shortage of organ donors encourages patients awaiting transplants to consider artificial organs, boosting their future popularity.
Artificial Organ Market Growth Drivers:
- Increasing Prevalence of Chronic Diseases: The rising incidence of chronic illnesses is driving the global artificial organs market, as these devices offer potential solutions for patients with organ dysfunction. Artificial organs can serve as temporary support before organ transplantation or as lifelong replacements. In America, heart disease, cancer, stroke, chronic lower respiratory diseases, and diabetes are leading causes of death, accounting for 702,880, 608,371, 165,393, 147,382, and 101,209 deaths, respectively, in 2023.
- Rising Aging Population: The growing global aging population is fueling the development of the artificial organ market. Age-related diseases, such as cardiovascular, kidney, respiratory, and neurodegenerative conditions, along with declining organ function, can lead to organ failure. In the US, the population aged 50 and older is projected to increase by 61.11%, from 137.25 million in 2020 to 221.13 million by 2050, and the prevalence of chronic illness is expected to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050.
Artificial Organ Market Geographical Outlook:
- North America: North America is a dominant market player due to its strong healthcare infrastructure, high adoption of advanced technologies, and a large patient population. For example, healthcare expenses in the US increased by 7.5% to $4.9 trillion in 2023, reaching $14,570 per person.
- Europe: Europe is well-established in the use of artificial organs due to its aging population and a robust healthcare system supported by government initiatives that emphasize research, innovative technologies, and development. The region's older population is projected to rise significantly, from 90.5 million in 2019 to 129.8 million by 2050.
- Asia-Pacific: The Asia-Pacific region is expected to experience substantial growth in the artificial organ market due to economic transformations, an increasing prevalence of chronic diseases among the aging population, rising government expenditures on healthcare facilities, and improved public awareness.
- Middle East and Africa: The artificial organ market in the Middle East and Africa is expected to strengthen, driven by investments in healthcare infrastructure, increasing government funding, and government efforts to improve healthcare access.
- South America: The South American region is experiencing rising sales of artificial organ products. With the increasing incidence of chronic diseases, growing awareness, and improvements in the health sector, the region is gradually establishing brand equity in the artificial organ sector.
Reasons for buying this report::
- Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
- Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
- Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
- Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
- Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What can businesses use this report for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence.Report Coverage:
- Historical data & forecasts from 2022 to 2030
- Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
- Competitive Positioning, Strategies, and Market Share Analysis
- Revenue Growth and Forecast Assessment of segments and regions including countries
- Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
Artificial Organ Market is analyzed into the following segments:
By Product Type
- Artificial Heart
- Artificial Kidney
- Artificial Lungs
- Artificial Liver
- Artificial Pancreas
- Cochlear Implants
- Other Types
By Organ Type
- Permanent Artificial Organs
- Temporary Artificial Organs
By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- United Kingdom
- Germany
- France
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Taiwan
- Australia
- Others
Table of Contents
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
5. GLOBAL ARTIFICIAL ORGAN MARKET BY PRODUCT TYPE
6. GLOBAL ARTIFICIAL ORGAN MARKET BY ORGAN TYPE
7. GLOBAL ARTIFICIAL ORGAN MARKET BY GEOGRAPHY
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
9. COMPANY PROFILES
Companies Mentioned
- Baxter
- Boston Scientific Corporation
- Asahi Kasei Medical
- Medtronic PLC
- Abiomed
- SynCardia Systems
- Carmat
- Getinge
- Terumo
- BiVACOR Inc
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 144 |
Published | February 2025 |
Forecast Period | 2025 - 2030 |
Estimated Market Value ( USD | $ 4.69 Billion |
Forecasted Market Value ( USD | $ 6.69 Billion |
Compound Annual Growth Rate | 7.3% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |